Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

被引：0
|
作者：
Zhong, Xinxin [1 ]
Lin, Ao [2 ]
Luo, Jian [1 ]
Li, Yeqin [1 ]
Chen, Jinlan [1 ]
Ning, Chao [1 ]
Cao, Fu [1 ,3 ]
机构：
[1] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, Yulin 537000, Guangxi, Peoples R China
[2] Red Cross Hosp Yulin City, Dept Cardiothorac Surg, Yulin 537000, Guangxi, Peoples R China
[3] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, 1 Jinwang Rd, Yulin 537000, Guangxi, Peoples R China
来源：
POSTGRADUATE MEDICAL JOURNAL | 2024年 / 100卷 / 1184期
关键词：
antituberculosis drugs; multidrug-resistance; mycobacterium; chemotherapy; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; IN-VITRO; MDR-TB; BEDAQUILINE; REGIMENS; PRETOMANID; DISCOVERY; DELAMANID; EFFICACY;
D O I：
10.1093/postmj/qgad140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
引用
收藏
页码：366 / 372
页数：7
相关论文
共 50 条
  • [41] Preventing multidrug-resistant tuberculosis
    Bloch, AB
    Simone, PM
    McCray, E
    Castro, KG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (06): : 487 - 489
  • [42] REINFECTION WITH MULTIDRUG-RESISTANT TUBERCULOSIS
    LIN, BTY
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (11): : 811 - 812
  • [43] CLUSTERS OF MULTIDRUG-RESISTANT TUBERCULOSIS
    EDLIN, BR
    VALWAY, SE
    ONORATO, IM
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (01) : 77 - 77
  • [44] Multidrug-resistant tuberculosis - This is the cost
    Moore-Gillon, J
    NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS, 2001, 953 : 233 - 240
  • [45] Quinolones and multidrug-resistant tuberculosis
    Maranetra, KN
    CHEMOTHERAPY, 1999, 45 : 12 - 18
  • [46] Managing multidrug-resistant tuberculosis
    Antoun, F.
    Veziris, N.
    REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (08) : 956 - 957
  • [47] Fluoroquinolones in multidrug-resistant tuberculosis
    Mohapatra, PR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) : 920 - 921
  • [48] Multidrug-resistant tuberculosis in India
    Tageja, Nishant
    Sharma, Vishal
    LANCET, 2010, 376 (9742): : 682 - 683
  • [49] An update on multidrug-resistant tuberculosis
    Park, Mirae
    Satta, Giovanni
    Kon, Onn Min
    CLINICAL MEDICINE, 2019, 19 (02) : 135 - 139
  • [50] Multidrug-resistant tuberculosis today
    Matteelli, A.
    Centis, R.
    D'Ambrosio, L.
    Migliori, G. B.
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2012, 90 (02) : 78 - 78
12345